Table II.

Number of CPE-positive patients and bed-days lost due to CPE

Variable	Phase 1	Phase 2	Phase 3
No. of months when data were collected	6	10	12
Total no. of positive patients	41	156	128
Mean no. positive patients/month	6.8	15.6	10.6
Total no. of bed closures	60	228	108
Mean bed-days lost per month (SD)	10.0 (8.4)	22.8 (13.6)	9.0 (8.3)
Mean wards/units affected	2.57	7.71	3.86

CPE, carbapenemase-producing Enterobacterales.